These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12498967)

  • 1. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia.
    Bär KJ; Franke S; Wenda B; Müller S; Kientsch-Engel R; Stein G; Sauer H
    Neurobiol Aging; 2003; 24(2):333-8. PubMed ID: 12498967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
    Haddad M; Perrotte M; Landri S; Lepage A; Fülöp T; Ramassamy C
    J Alzheimers Dis; 2019; 69(3):751-762. PubMed ID: 31127773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?
    Monacelli F; Borghi R; Pacini D; Serrati C; Traverso N; Odetti P
    Clin Chem Lab Med; 2014 Jan; 52(1):117-20. PubMed ID: 23612599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.
    O'Grady KL; Khosla S; Farr JN; Bondar OP; Atkinson EJ; Achenbach SJ; Eckhardt BA; Thicke BS; Tweed AJ; Volkman TL; Drake MT; Hines JM; Singh RJ
    J Appl Lab Med; 2020 May; 5(3):558-568. PubMed ID: 32445362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum pentosidine as an indicator of Alzheimer's disease.
    Meli M; Perier C; Ferron C; Parssegny F; Denis C; Gonthier R; Laurent B; Reynaud E; Frey J; Chamson A
    J Alzheimers Dis; 2002 Apr; 4(2):93-6. PubMed ID: 12214132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
    Hein G; Wiegand R; Lehmann G; Stein G; Franke S
    Rheumatology (Oxford); 2003 Oct; 42(10):1242-6. PubMed ID: 12777635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product.
    Takahashi M; Oikawa M; Nagano A
    J Gerontol A Biol Sci Med Sci; 2000 Mar; 55(3):M137-40. PubMed ID: 10795725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain.
    Jono T; Kimura T; Takamatsu J; Nagai R; Miyazaki K; Yuzuriha T; Kitamura T; Horiuchi S
    Pathol Int; 2002 Sep; 52(9):563-71. PubMed ID: 12406185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
    Castellani RJ; Harris PL; Sayre LM; Fujii J; Taniguchi N; Vitek MP; Founds H; Atwood CS; Perry G; Smith MA
    Free Radic Biol Med; 2001 Jul; 31(2):175-80. PubMed ID: 11440829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
    Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
    Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
    Kimura T; Takamatsu J; Miyata T; Miyakawa T; Horiuchi S
    Pathol Int; 1998 Aug; 48(8):575-9. PubMed ID: 9736403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of advanced glycation end products in human cataractous lenses.
    Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
    J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
    Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
    J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of pentosidine, an advanced glycation end-product, in umbilical cord blood.
    Tsukahara H; Ohta N; Sato S; Hiraoka M; Shukunami K; Uchiyama M; Kawakami H; Sekine K; Mayumi M
    Free Radic Res; 2004 Jul; 38(7):691-5. PubMed ID: 15453634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
    Foroumandi E; Alizadeh M; Kheirouri S; Asghari Jafarabadi M
    PLoS One; 2019; 14(3):e0213307. PubMed ID: 30856212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia?
    Hein G; Franke S
    Rheumatology (Oxford); 2002 Oct; 41(10):1163-7. PubMed ID: 12364637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.